Birdwatch Archive

Birdwatch Note Rating

2024-05-25 23:09:56 UTC - HELPFUL

Rated by Participant: F5BA5675F5BDE33CBF86EC2C252499E31A1C1E896EB2FCE821D68C7083873B4C
Participant Details

Original Note:

O estudo faz uma comparação dos resultados em pacientes com diabetes e doença renal crônica. E a dosagem recomendada era p/ diabéticos, conforme a bula, e não para obesidade, durante um período de 3 anos. Os benefícios foram confirmados exclusivamente nesse grupo de pacientes. www.washingtonpost.com/health/2024/05/24/ozempic-kidney-disease-study

All Note Details

Original Tweet

All Information

  • noteId - 1794483552173662356
  • participantId -
  • raterParticipantId - F5BA5675F5BDE33CBF86EC2C252499E31A1C1E896EB2FCE821D68C7083873B4C
  • createdAtMillis - 1716678596545
  • version - 2
  • agree - 0
  • disagree - 0
  • helpful - 0
  • notHelpful - 0
  • helpfulnessLevel - HELPFUL
  • helpfulOther - 0
  • helpfulInformative - 0
  • helpfulClear - 1
  • helpfulEmpathetic - 0
  • helpfulGoodSources - 0
  • helpfulUniqueContext - 0
  • helpfulAddressesClaim - 1
  • helpfulImportantContext - 0
  • helpfulUnbiasedLanguage - 0
  • notHelpfulOther - 0
  • notHelpfulIncorrect - 0
  • notHelpfulSourcesMissingOrUnreliable - 0
  • notHelpfulOpinionSpeculationOrBias - 0
  • notHelpfulMissingKeyPoints - 0
  • notHelpfulOutdated - 0
  • notHelpfulHardToUnderstand - 0
  • notHelpfulArgumentativeOrBiased - 0
  • notHelpfulOffTopic - 0
  • notHelpfulSpamHarassmentOrAbuse - 0
  • notHelpfulIrrelevantSources - 0
  • notHelpfulOpinionSpeculation - 0
  • notHelpfulNoteNotNeeded - 0
  • ratingsId - 1794483552173662356F5BA5675F5BDE33CBF86EC2C252499E31A1C1E896EB2FCE821D68C7083873B4C